Back to search
Corticobasal Syndrome (CBS)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Corticobasal Syndrome (CBS) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Corticobasal Syndrome (CBS) trials you may qualify forThe aim of this study is to create a repository of both cross-sectional and longitudinal data, including cognitive, linguistic, imaging and biofluid biological…
This study is an observational, prospective genetic study. It aims to obtain DNA for research and testing from patients with PSP, CBS, MSA, and related neurolog…
The current protocol is to determine the biodistribution, metabolism, excretion and brain uptake of 18F-JSS20-183A. The goal of this radiotracer is to quantify…
The primary goal of this study is to investigate inflammation and white matter damage in corticobasal syndrome and determine whether these processes are related…
The primary objective of this clinical study is to provide the initial validation for monitoring biomarkers of symptoms and functioning for individuals with fro…
The primary objective of this clinical study is to provide the initial validation for monitoring biomarkers of symptoms and functioning for individuals with FTL…
Corticobasal syndrome (CBS) is a rapidly progressive neurodegenerative disorder with an average survival time of about 6-8 years after the first clinical manife…